349 related articles for article (PubMed ID: 28131394)
1. Novel adenovirus encoded virus-like particles displaying the placental malaria associated VAR2CSA antigen.
Andersson AC; Resende M; Salanti A; Nielsen MA; Holst PJ
Vaccine; 2017 Feb; 35(8):1140-1147. PubMed ID: 28131394
[TBL] [Abstract][Full Text] [Related]
2. Murine Model for Preclinical Studies of Var2CSA-Mediated Pathology Associated with Malaria in Pregnancy.
de Moraes LV; Dechavanne S; Sousa PM; Barateiro A; Cunha SF; Nunes-Silva S; Lima FA; Murillo O; Marinho CRF; Gangnard S; Srivastava A; Braks JA; Janse CJ; Gamain B; Franke-Fayard B; Penha-Gonçalves C
Infect Immun; 2016 Jun; 84(6):1761-1774. PubMed ID: 27045035
[TBL] [Abstract][Full Text] [Related]
3. Structure of the DBL3X-DBL4ε region of the VAR2CSA placental malaria vaccine candidate: insight into DBL domain interactions.
Gangnard S; Lewit-Bentley A; Dechavanne S; Srivastava A; Amirat F; Bentley GA; Gamain B
Sci Rep; 2015 Oct; 5():14868. PubMed ID: 26450557
[TBL] [Abstract][Full Text] [Related]
4. A Novel Virus-Like Particle Based Vaccine Platform Displaying the Placental Malaria Antigen VAR2CSA.
Thrane S; Janitzek CM; Agerbæk MØ; Ditlev SB; Resende M; Nielsen MA; Theander TG; Salanti A; Sander AF
PLoS One; 2015; 10(11):e0143071. PubMed ID: 26599509
[TBL] [Abstract][Full Text] [Related]
5. Antibodies to Escherichia coli-expressed C-terminal domains of Plasmodium falciparum variant surface antigen 2-chondroitin sulfate A (VAR2CSA) inhibit binding of CSA-adherent parasites to placental tissue.
Saveria T; Oleinikov AV; Wiliamson K; Chaturvedi R; Lograsso J; Keitany GJ; Fried M; Duffy P
Infect Immun; 2013 Apr; 81(4):1031-9. PubMed ID: 23319559
[TBL] [Abstract][Full Text] [Related]
6. Differential induction of functional IgG using the Plasmodium falciparum placental malaria vaccine candidate VAR2CSA.
Pinto VV; Ditlev SB; Jensen KE; Resende M; Dahlbäck M; Andersen G; Andersen P; Theander TG; Salanti A; Nielsen MA
PLoS One; 2011 Mar; 6(3):e17942. PubMed ID: 21464946
[TBL] [Abstract][Full Text] [Related]
7. Identification of Id1-DBL2X of VAR2CSA as a key domain inducing highly inhibitory and cross-reactive antibodies.
Bordbar B; Tuikue-Ndam N; Bigey P; Doritchamou J; Scherman D; Deloron P
Vaccine; 2012 Feb; 30(7):1343-8. PubMed ID: 22226864
[TBL] [Abstract][Full Text] [Related]
8. VAR2CSA binding phenotype has ancient origin and arose before Plasmodium falciparum crossed to humans: implications in placental malaria vaccine design.
Gangnard S; Chêne A; Dechavanne S; Srivastava A; Avril M; Smith JD; Gamain B
Sci Rep; 2019 Nov; 9(1):16978. PubMed ID: 31740695
[TBL] [Abstract][Full Text] [Related]
9. The chondroitin sulfate A-binding site of the VAR2CSA protein involves multiple N-terminal domains.
Dahlbäck M; Jørgensen LM; Nielsen MA; Clausen TM; Ditlev SB; Resende M; Pinto VV; Arnot DE; Theander TG; Salanti A
J Biol Chem; 2011 May; 286(18):15908-17. PubMed ID: 21398524
[TBL] [Abstract][Full Text] [Related]
10. Designing a VAR2CSA-based vaccine to prevent placental malaria.
Fried M; Duffy PE
Vaccine; 2015 Dec; 33(52):7483-8. PubMed ID: 26469717
[TBL] [Abstract][Full Text] [Related]
11. A single full-length VAR2CSA ectodomain variant purifies broadly neutralizing antibodies against placental malaria isolates.
Doritchamou JYA; Renn JP; Jenkins B; Mahamar A; Dicko A; Fried M; Duffy PE
Elife; 2022 Feb; 11():. PubMed ID: 35103596
[TBL] [Abstract][Full Text] [Related]
12. Structural and functional insight into how the Plasmodium falciparum VAR2CSA protein mediates binding to chondroitin sulfate A in placental malaria.
Clausen TM; Christoffersen S; Dahlbäck M; Langkilde AE; Jensen KE; Resende M; Agerbæk MØ; Andersen D; Berisha B; Ditlev SB; Pinto VV; Nielsen MA; Theander TG; Larsen S; Salanti A
J Biol Chem; 2012 Jul; 287(28):23332-45. PubMed ID: 22570492
[TBL] [Abstract][Full Text] [Related]
13. The Influence of Sub-Unit Composition and Expression System on the Functional Antibody Response in the Development of a VAR2CSA Based Plasmodium falciparum Placental Malaria Vaccine.
Nielsen MA; Resende M; de Jongh WA; Ditlev SB; Mordmüller B; Houard S; Ndam NT; Agerbæk MØ; Hamborg M; Massougbodji A; Issifou S; Strøbæk A; Poulsen L; Leroy O; Kremsner PG; Chippaux JP; Luty AJ; Deloron P; Theander TG; Dyring C; Salanti A
PLoS One; 2015; 10(9):e0135406. PubMed ID: 26327283
[TBL] [Abstract][Full Text] [Related]
14. The antibody response of pregnant Cameroonian women to VAR2CSA ID1-ID2a, a small recombinant protein containing the CSA-binding site.
Babakhanyan A; Leke RG; Salanti A; Bobbili N; Gwanmesia P; Leke RJ; Quakyi IA; Chen JJ; Taylor DW
PLoS One; 2014; 9(2):e88173. PubMed ID: 24505415
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity of Duffy binding-like domains that bind chondroitin sulfate A and protection against pregnancy-associated malaria.
Bir N; Yazdani SS; Avril M; Layez C; Gysin J; Chitnis CE
Infect Immun; 2006 Oct; 74(10):5955-63. PubMed ID: 16988275
[TBL] [Abstract][Full Text] [Related]
16. Antibodies to a full-length VAR2CSA immunogen are broadly strain-transcendent but do not cross-inhibit different placental-type parasite isolates.
Avril M; Hathaway MJ; Srivastava A; Dechavanne S; Hommel M; Beeson JG; Smith JD; Gamain B
PLoS One; 2011 Feb; 6(2):e16622. PubMed ID: 21326877
[TBL] [Abstract][Full Text] [Related]
17. Chondroitin sulfate A-adhering Plasmodium falciparum-infected erythrocytes express functionally important antibody epitopes shared by multiple variants.
Barfod L; Dobrilovic T; Magistrado P; Khunrae P; Viwami F; Bruun J; Dahlbäck M; Bernasconi NL; Fried M; John D; Duffy PE; Salanti A; Lanzavecchia A; Lim CT; Ndam NT; Higgins MK; Hviid L
J Immunol; 2010 Dec; 185(12):7553-61. PubMed ID: 21078904
[TBL] [Abstract][Full Text] [Related]
18. Strain-transcendent immune response to recombinant Var2CSA DBL5-ε domain block P. falciparum adhesion to placenta-derived BeWo cells under flow conditions.
Fernandez P; Petres S; Mécheri S; Gysin J; Scherf A
PLoS One; 2010 Sep; 5(9):e12558. PubMed ID: 20838433
[TBL] [Abstract][Full Text] [Related]
19. Immunization with recombinant duffy binding-like-gamma3 induces pan-reactive and adhesion-blocking antibodies against placental chondroitin sulfate A-binding Plasmodium falciparum parasites.
Costa FT; Fusaï T; Parzy D; Sterkers Y; Torrentino M; Douki JB; Traoré B; Petres S; Scherf A; Gysin J
J Infect Dis; 2003 Jul; 188(1):153-64. PubMed ID: 12825185
[TBL] [Abstract][Full Text] [Related]
20. Structural insights into chondroitin sulphate A binding Duffy-binding-like domains from Plasmodium falciparum: implications for intervention strategies against placental malaria.
Gill J; Chitnis CE; Sharma A
Malar J; 2009 Apr; 8():67. PubMed ID: 19374733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
